Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-09

Clinical Trial Update: The Effect of 5-Hydroxytryptophan (5-HTP) on Satiety [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates whether 5-hydroxytryptophan (5-HTP) affects satiety in obesity participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Hydroxytryptophan (5-HTP)

Snippet

Sponsor: TNO | Conditions: Obesity | Phase 2 | Status: COMPLETED